References
- AdamsNLassersonTJCatesCJFluticasone versus beclomethasone or budesonide for chronic asthma in adults and childrenCochrane Database Syst Rev20074CD00231017943772
- Al SayyadJJFedorowiczZAlhashimiDTopical nasal steroids for intermittent and persistent alergic rhinitis in childrenCochrane Database Syst Rev20071CD00316317253485
- AllenADownGNewlandsATolerability, safety, pharmacokinetics and bioavailability of the novel intranasal corticosteroid fluticasone furoate in healthy subjects [abstract no P210]Ann Allergy Asthma Immunol200798A89
- AntonicelliLMicucciCVoltoliniSRelationship between ARIA classification and drug treatment in allergic rhinitis and asthmaAllergy20076210647017686109
- BergerWGodfreyJWGrantACFluticasone furoate (FF) nasal spray: development of a next-generation delivery system for allergic rhinitis [abstract no 907]J Allergy Clin Immunol2007119S231
- BernsteinILIs the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautinary note based on compromised mucociliary transportJ Allergy Clin Immunol2000105394410629450
- BiggadikeKBledsoeRHassellAFluticasone furoate (FF): interactions with the glucocorticoid receptor [abstract no P219]Ann Allergy Asthma Immunol200798A912
- BousquetJVan CauwenbergePKhaltaevNARIA Workshop Group. Allergic rhinitis and its impact on asthmaJ Allergy Clin Immunol2001108S133311449199
- BraatJAingeGBowlesJAThe lack of effect of benzalkonium chloride on the cilia of the nasal mucosa in patients with perennial allergic rhinitis: a combined functional, light, scanning and transmission electron microscopy studyClin Exp Allergy199525957658556567
- BrandPLPInhaled corticosteroids reduce growth. Or do they?Eur Respir J2001172879411334133
- CorrenJIntranasal corticosteroids for allergic rhinitis: How do different agents compare?J Allergy Clin Immunol1999104S144910518811
- CraigTJTeetsSLehmanEBNasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroidsJ Allergy Clin Immunol199810163379600500
- Crystal-PetersJCrownWHGoetzelRZThe cost of productivity losses associated with allergic rhinitisAm J Manag Care20006373810977437
- Crystal-PetersJNeslusanCCrownWHTreating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department visitsJ Allergy Clin Immunol2002109576211799366
- DimovaSMugabowindekweRWillemsTSafety-assessment of 3-methoxyquercetin as an anthirhinoviral compund for nasal application: effect on ciliary beat frequencyInt J Pharm20032639510312954184
- EnglishAFNeateMSQuintDJBiological activities of some corticosteroids used in asthmaAm J Respir Crit Care Med1994149A212
- FDAVeramyst™ (fluticasone furoate) nasal spray: US prescribing information [online] Accessed 2007 Dec 17. URL: http://www.fda.gov/cder/
- FokkensWJJogiRReinartzSOnce daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollenAllergy2007a6210788417686111
- FokkensWJoggiRSidorenkoIFluticasone furoate nasal spray (FFNS) 110 mcg once-daily is effective in seasonal allergic rhinitis (SAR) caused by grass pollen [abstract no. 352]2007bXXVI Congress of the European Academy of Allergology and Clinical ImmunologyJun 9-13, 2007Göteborg
- GivenJTolerTEllsworthAOnce-daily fluticasone furoate nasal spray (FFNS) 110 mcg improves quality of life (QoL) in subjects with seasonal allergic rhinitis (SAR) during the ragweed season [abstract no 1188]J Allergy Clin Immunol2007119S304
- GlaxoSmithKline.Veramyst™ Accessed 2007 Dec 17. URL: http://www.gsk.com/
- GradmanJCaldwellMWolthersOKnemometric assessment of short-term lower-leg growth in children with allergic rhinitis (AR) treated with fluticasone furoate (FF) nasal spray [abstract no 1187]J Allergy Clin Immunol2007119S304
- GulliverTEidNEffects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adultsImmunol Allergy Clin N Am20052554155
- HampelFCJrJacobsRMartinBOnce-daily fluticasone furoate nasal spray (FF) provides 24-hour symptom relief in subjects with seasonal allergic rhinitis (SAR) caused by mountain cedar pollen [abstract no 1190]J Allergy Clin Immunol2007119S3045
- HofmannTGugatschgaMKoidlBInfluence of preservatives and topical steroids on ciliary beat frequency in vitroArch Otolaryngol Head Neck Surg2004130440515096427
- HübnerMHochhausGDerendorfHComparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroidsImmunol Allergy Clin N Am20052546988
- HughesSShardlowPRousellVDisposition and metabolism of a novel enhanced affinity glucocorticoid, [14C]-fluticasone furoate (FF) after oral and intravenous (IV) administration in healthy male subjects [abstract no P216]Ann Allergy Asthma Immunol200798A901
- International Rhinitis Management Working GroupInternational Consensus Report on the diagnosis and management of rhinitisAllergy199449134
- JuniperEFGuyattGHArcherBAqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of “as needed” useJ Allergy Clin Immunol19939266728335858
- KaiserHBNaclerioRMGivenJFluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitisJ Allergy Clin Immunol20071191430717418384
- LeynaertBNeukirchCLiardRQuality of life in allergic rhinitis and asthma: a population based study of young adultsAm J Respir Crit Care Med2000a1621391611029350
- LeynaertBNeukirchFDemolyPEpidemiological evidence for asthma and rhinitis comorbidityJ Allergy Clin Immunol2000b106S201511080732
- LinnebergAHenrik NielsenNFrolundLCopenhagen Allergy Study. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy StudyAllergy20025710485212359002
- MahadeviaPJShahSLeibmanCPatient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysisAnn Allergy Asthma Immunol2004933455015521370
- MarpleBRolanfPBenningerMSafety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinionsOtolaryngol Head Neck Surg20041301314114726922
- MartinBGRatnerPHHampelFCOptimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescentsAllergy Asthma Proc2007282162517479608
- MasperoJFRosenblutAFinnAJrOnce-daily fluticasone furoate nasal spray (FF) is safe and effective in the long-term treatment of perennial allergic rhinitis (PAR) in children ages 2 to 11 years [abstract no 1189]J Allergy Clin Immunol2007119S304
- McCormackPLScottLJFluticasone furoate: intranasal use in allergic rhinitisDrugs20076719051517722960
- McKenzieAWPercutaneous absorption of steroidsArch Dermatol1962866114
- McMahonCDarbyYRyanRImmediate and short-term effects of benzalkonium chloride on the human nasal mucosa in vivoClin Otolaryngol Allied Sci199722318229298605
- MeltzerEOBardelasJGoldsobelAA preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitisTreat Respir Med200542899616086602
- MeltzerEOFormulation considerations of intranasal corticosteroids for the treatment of allergic rhinitisAnn Allergy Asthma Immunol200798122117225715
- MeltzerEOTripathyILeeJOnce-daily fluticasone furoate nasal spray (FF) provides 24-hour relief of the nasal symptoms of seasonal allergic rhinitis (SAR) in children ages 2-11 years [abstract no 1193]J Allergy Clin Immunol2007a119S305
- MeltzerEOLeeJTripathyIStudy to assess the efficacy and safety of two doses of fluticasone furoate nasal spray in children with seasonal allergic rhinitis [abstract no 343]2007bXXVI Congress of the European Academy of Allergology and Clinical Immunology2007 Jun 9-13Göteborg
- NathanRBergerWYangWOnce daily fluticasone furoate nasal spray (FFNS), a novel enhanced affinity steroid, provides 24-hour relief for the nasal symptoms of perennial allergic rhinitis (PAR) [abstract no 254]J Allergy Clin Immunol2007119S65
- O’ConnellEJThe burden of atopy and asthma in childrenAllergy20045971115245350
- OppligerRHauserCAnaphylaxis after injection of corticosteroid preparations-carboxymethylcellulose as a hidden allergen [in German]J Dtsch Dermatol Ges200429283016281611
- PastelDRatnerPClementsDLack of efect on hypothalamic-pituitary-adrenal (HPA) axis function by once-daily fluticasone furoate nasal spray (FFNS) 110 mcg in adolescents and adults with perennial allergic rhinitis [abstract no 909]J Allergy Clin Immunol2007119S305
- PattersonDLYungingerJWDunnWFAnaohykaxis induced by carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog)Ann Allergy Asthma Immunol19957416367697477
- PriceDBondCBouchardJInternational Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitisPrim Care Respir J200615587016701759
- RaoVUApterAJSteroid phobia and adherence-problems, solutions, impact on benefit/risk profileImmunol Allergy Clin N Am20052558195
- RatnerPAndrewsCvan BavelJOnce-daily fluticasone furoate nasal spray (FF) effectively treats ocular symptoms of seasonal allergic rhinitis (SAR) caused by mountain cedar pollen [abstract no 908]J Allergy Clin Immunol2007119S231
- RiechelmannHDeutschleTStuhlmillerANasal toxicity of benzalkonium chlorideAm J Rhinol200418291915586800
- RosenblutABardinPGMullerBLong-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitisAllergy2007621071717686110
- RxListThe internet drug index Veramyst™ Accessed 2007 Dec 17. URL: http://www.rxlist.com/cgi/generic/veramyst/
- SalterMBiggadikeKClackersMGW685698X – enhanced affinity for the glucocorticoid receptor: cellular and in nvivo pharmacology [abstract no 781]200625th Congress of the European Academy of Allergology and Clinical Immunology2006, Jun 10-14Vienna
- SalterMBiggadikeKClackersMFluticasone furoate (FF): enhanced cellular and tissue protection with a new selective glucocorticoid agonist [abstract no P212]Ann Allergy Asthma Immunol200798A89
- SchoenwetterWFDupclayLJrAppajosyulaSEconomic impact and quality-of-life burden of allergic rhinitisCurr Med Res Opin2004203051715025839
- ShelleyWBTalaninNShelleyEDPolysorbate 80 hypersensitivityLancet19953451312137746084
- StanfordRPhilpotEFarisMFluticasone furoate nasal spray once-daily improves quality of life in subjects with seasonal allergic rhinitis (SAR) [abstract no P214]Ann Allergy Asthma Immunol2007a98A90
- StanfordRPhilpotEFarisMFluticasone furoate nasal spray once-daily improves nocturnal quality of life in subjects with seasonal allergic rhinitis (SAR) [abstract no P208]Ann Allergy Asthma Immunol2007b98A889
- SteinsvagSKBjerknesRBergOHEffects of topical nasal steroids on human respiratory mucosa and human granulocytes in vitroActa Otolaryngol1996116868758973724
- StuebnerPEffects of the novel intranasal glucocorticosteroid GW685698 (200 mcg once-daily) on seasonal allergic rhinitis (SAR) symptoms induced in the Vienna challenge chamber model (VCC) [abstract no 1232]J Allergy Clin Immunol2006117S319
- TaramarcazPGibsonPGIntranasal corticosteroids for asthma control in people with coexisting asthma and rhinitisCochrane Database Syst Rev20033CD00357014583983
- The International Study of Asthma and Allergies I Childhood (ISAAC) Steering committeeWorldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAACLancet19983511225329643741
- TogiasARhinitis and asthma: evidence for respiratory system integrationJ Allergy Clin Immunol200311111718312789212
- TripathyISterlingRClementsDLack of efect on hypothalamic-pituitary-adrenal (HPA) axis function by once-daily fluticasone furoate nasal spray (FFNS) 110 mcg in children with perennial allergic rhinitis [abstract no. 909]J Allergy Clin Immunol2007119S232
- UmlandSPNarhebneDKRazacBSThe inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-[gama] production by cultured primary CD4+ cellsJ Allergy Clin Immunol199710051199338546
- UptonMNMcConnachieAMcsharryCIntergeneration 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspringBr Med J2000321889210884260
- van BavelJTolerTEllsworthAOnce-daily fluticasone furoate nasal spray (FFNS) improves quality of life (QoL) in subjects with seasonal allergic rhinitis (SAR) during the mountatin cedar pollen season [abstract no 903]J Allergy Clin Immunol2007119S230
- van CauwenbergePVan HoeckeHVandenbulckeLGlucocorticosteroids in allergic inflammation: clinical benefits in allergic rhinitis, rhinosinusitis, and otitis mediaImmunol Allergy Clin N Am200525489509
- VasarMHouleP-ADouglassJAA novel enhanced-affinity corticosteroid, once daily fluticasone furoate nasal spray (FFNS), provides 24-hour relief for the nasal symptoms of perennial allergic rhinitis (PAR) [abstract no 626]2007XXVI Congress of the European Academy of Allergology and Clinical Immunology 2007Jun 9-13Göteborg
- VerretDJMarpleBFEffect of topical nasal steroid sprays on nasal mucosa and ciliary functionCurr Opin Otolaryngol Head Neck Surg200513141815654209
- WeinerJMAbramsonMJPuyRMIntranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trialsBr Med J1998317162499848901
- YawnBPYungingerJWWollanPCAllergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care chargesJ Allergy Clin Immunol19991035499893185